http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-52166-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2008-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67552b7b38aea238f899d93ce62fa988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8268630c6f041daf5b3c4f3ddefdff58 |
| publicationDate | 2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RS-52166-B |
| titleOfInvention | AMINO-HETEROCYCLIC COMPOUNDS |
| abstract | The compound of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: R is selected from the group consisting of (C1-C6) alkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C3-C8) cycloalkyl, heterocycloalkyl, aryl and heteroaryl groups, each of which may be optionally substituted with one to three substituents, the substituents are independently selected from the group consisting of (C1-C4) alkyl, (C1-C4) alkoxy, halo and (C1-C4) ) haloalkyl.R1 is selected from the group consisting of hydrogen, (C1-C4) alkyl, (C2-C4) alkenyl, (C2-C4) alkynyl, (C1-C4) haloalkyl and cyclopropyl, R2 is selected from the group consisting of ( C1-C6) alkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C1-C6) haloalkyl, a heteroaryl group selected from the group consisting of pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, and an ER5 group, wherein the heteroaryl group may be optionally substituted with one to three substituents independently selected from the group consisting of (C1-C4) alkyl and (C1-C4) haloalkyl, R3 is selected from the group consisting of hydrogen, (C1-C4) alkyl, ( C2-C4) alkenyl, (C2-C4) alkynyl, C3-C6) cycloalkyl and (C1-C4) haloalkyl, E is selected from the group consisting of -CH2-, -CH2CH2-, -CH2CH2CH2-, and -C (O) -, R5 is selected from the group consisting of -C8) cycloalkyl, heterocycloalkyl, aryl, aryloxy and heteroaryl groups, each of which may be optionally substituted with one to three substituents, and these substituents are independently selected from the group consisting of (C1-C4) alkyl, (C2-C4 ) alkenyl, (C2-C4) alkynyl, (C1-C4) hydroxyalkyl, (C1-C4) haloalkyl, (C1-C4) alkoxy, (C1-C4) haloalkoxy, (C3-C8) cycloalkyl, halo, cyano, phenyl , morpholinyl, (C1-C4) alkylamino, pyrazolyl, triazolyl and imidazolyl. The application contains 15 more claims. |
| priorityDate | 2007-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394295 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451 |
Total number of triples: 32.